News

Sarepta Makes Big Cuts After Patient Deaths. Its Prospects Remain Uncertain.
The pharma company said it would lay off a third of its workforce and add a black-box warning to its controversial gene ...
Sarepta Soars as Gene Therapy Stays on Market With Warning
Sarepta Therapeutics Inc. shares soared after the company said it was cutting more than a third of its workforce and that its ...
BioSpace1h
Sarepta Up 18% After Business Overhaul as Analysts Cautiously Optimistic
Sarepta Therapeutics appears to have right-sized itself after laying off over a third of its staff, announcing a significant ...
GEN - Genetic Engineering and Biotechnology News13h
Sarepta Axes 500, 36% of Workforce, in Restructuring after DMD Patient Deaths
Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...
The Pharma Letter5h
Sarepta leaps on strategic restructuring and pipeline prioritization
US rare disease meds developer Sarepta Therapeutics late yesterday announced a strategic restructuring plan designed to ...
STAT20h
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...
Explore more
Sarepta Stock Soars 30%. Why Layoffs and a ‘Black-Box’ Warning Are Good News.
Sarepta stock surged after the pharma company said it would lay off a third of its workforce and add a black-box warning to ...
Thursday movers: Taiwan Semi, Sarepta Therapeutics, MP Materials
TSMC shares rose 4% in premarket trade as the contract chip manufacturer lifted its 2025 sales guidance. Sarepta Therapeutics stock jumped 34% as the company set plans to lay off more than a third of ...